Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-148612
Filing Date
2022-05-12
Accepted
2022-05-12 16:02:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d325081ddefa14a.htm DEFA14A 9800
  Complete submission text file 0001193125-22-148612.txt   10800
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39567 | Film No.: 22917655
SIC: 2836 Biological Products, (No Diagnostic Substances)